Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery

Hearing Research

Volumn 255, Issue 1-2, 2009, Pages 67-72

  Chang, Andrew ^a   Eastwood, Hayden ^a   Sly, David ^a   James, David ^a   Richardson, Rachael ^a,b   O'Leary, Stephen ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BIONIC EAR INSTITUTE   (Australia)

Author keywords

Cochlear implantation; Dexamethasone; Pharmacokinetic; Residual hearing; Round window membrane

Indexed keywords

CARBOXYMETHYLCELLULOSE; DEXAMETHASONE; HYALURONIC ACID;

ADULT ANIMAL; ANIMAL EXPERIMENT; ARTICLE; AUDITORY THRESHOLD; COCHLEA; COCHLEA FENESTRA; COCHLEA PROSTHESIS; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DIFFUSION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; EAR PROTECTION; EVOKED BRAIN STEM AUDITORY RESPONSE; EXPERIMENTAL MODEL; GUINEA PIG; HEARING; IMPLANTATION; NONHUMAN; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; SURGICAL TECHNIQUE;

ANIMALS; COCHLEAR IMPLANTATION; COCHLEAR IMPLANTS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GUINEA PIGS; HEARING LOSS; ROUND WINDOW, EAR;

EID: 67651208331     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2009.05.010     Document Type: Article

References (37)

1. Adunka O., Roush P., Grose J., Macpherson C., and Buchman C.A. Monitoring of cochlear function during cochlear implantation. Laryngoscope 116 (2006) 1017-1020
2. Borenstein J.T., Weinberg E.J., Orrick B.K., Sundback C., Kaazempur-Mofrad M.R., and Vacanti J.P. Microfabrication of three-dimensional engineered scaffolds. Tissue Eng. 13 (2007) 1837-1844
3. Borkholder D.A. State-of-the-art mechanisms of intracochlear drug delivery. Curr. Opin. Otolaryngol. Head Neck Surg. 16 (2008) 472-477
4. Chandrasekhar S.S. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol. Neurotol. 22 (2001) 18-23
5. Chen Z., Kujawa S.G., McKenna M.J., Fiering J.O., Mescher M.J., Borenstein J.T., Swan E.E., and Sewell W.F. Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. J. Control. Release 110 (2005) 1-19
6. Cope D., and Bova R. Steroids in otolaryngology. Laryngoscope 118 (2008) 1556-1560
7. Dodson K.M., Woodson E., and Sismanis A. Intratympanic steroid perfusion for the treatment of Meniere's disease: a retrospective study. Ear Nose Throat J. 83 (2004) 394-398
8. Eshraghi A.A. Prevention of cochlear implant electrode damage. Curr. Opin. Otolaryngol. Head Neck Surg. 14 (2006) 323-328
9. Eshraghi A.A., Adil E., He J., Graves R., Balkany T.J., and Van De Water T.R. Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol. Neurotol. 28 (2007) 842-849
10. Gantz B.J., and Turner C. Combining acoustic and electrical speech processing: Iowa/Nucleus hybrid implant. Acta Otolaryngol. 124 (2004) 344-347
11. Gifford R.H., Dorman M.F., McKarns S.A., and Spahr A.J. Combined electric and contralateral acoustic hearing: word and sentence recognition with bimodal hearing. J. Speech Lang. Hear. Res. 50 (2007) 835-843
12. Gouveris H., Selivanova O., and Mann W. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur. Arch. Otorhinolaryngol. 262 (2005) 131-134
13. Goycoolea M.V. Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol. 121 (2001) 437-447
14. Gstoettner W., Kiefer J., Baumgartner W.D., Pok S., Peters S., and Adunka O. Hearing preservation in cochlear implantation for electric acoustic stimulation. Acta Otolaryngol. 124 (2004) 348-352
15. Gstoettner W.K., Van De Heyning P., O'Connor A.F., Morera C., Sainz M., Vermeire K., McDonald S., Cavalle L., Helbig S., Valdecasas J.G., Anderson I., and Adunka O.F. Electric acoustic stimulation of the auditory system: results of a multi-centre investigation. Acta Otolaryngol. 1 (2008) 8
16. Hahn H., Kammerer B., DiMauro A., Salt A.N., and Plontke S.K. Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration. Hear. Res. 212 (2006) 236-244
17. Ichimiya I., Yoshida K., Hirano T., Suzuki M., and Mogi G. Significance of spiral ligament fibrocytes with cochlear inflammation. Int. J. Pediatr. Otorhinolaryngol. 56 (2000) 45-51
18. James C.J., Fraysse B., Deguine O., Lenarz T., Mawman D., Ramos A., Ramsden R., and Sterkers O. Combined electroacoustic stimulation in conventional candidates for cochlear implantation. Audiol. Neurootol. 11 Suppl. 1 (2006) 57-62
19. James D.P., Eastwood H., Richardson R.T., and O'Leary S.J. Effects of round window dexamethasone on residual hearing in a Guinea pig model of cochlear implantation. Audiol. Neurootol. 13 (2008) 86-96
20. Kopke R.D., Wassel R.A., Mondalek F., Grady B., Chen K., Liu J., Gibson D., and Dormer K.J. Magnetic nanoparticles: inner ear targeted molecule delivery and middle ear implant. Audiol. Neurootol. 11 (2006) 123-133
21. Lehnhardt E. Intracochlear placement of cochlear implant electrodes in soft surgery technique. HNO 41 (1993) 356-359
22. Lenarz T., Stover T., Buechner A., Paasche G., Briggs R., Risi F., Pesch J., and Battmer R.D. Temporal bone results and hearing preservation with a new straight electrode. Audiol. Neurootol. 11 Suppl. 1 (2006) 34-41
23. Li P.M., Somdas M.A., Eddington D.K., and Nadol Jr. J.B. Analysis of intracochlear new bone and fibrous tissue formation in human subjects with cochlear implants. Ann. Otol. Rhinol. Laryngol. 116 (2007) 731-738
24. Maeda K., Yoshida K., Ichimiya I., and Suzuki M. Dexamethasone inhibits tumor necrosis factor-alpha-induced cytokine secretion from spiral ligament fibrocytes. Hear. Res. 202 (2005) 154-160
25. Mathivanar R., Anderson N., Harman D., Skalsky M., and Ng M. In vivo elution rate of drug eluting ceramic leads with a reduced dose of dexamethasone sodium phosphate. Pacing Clin. Electrophysiol. 13 (1990) 1883-1886
26. Mercanzini A., Reddy S., Velluto D., Colin P., Maillard A., Bensadoun J.C., Bertsch A., Hubbell J.A., and Renaud P. Controlled release drug coatings on flexible neural probes. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007 (2007) 6613-6616
27. Pettingill L.N., Minter R.L., and Shepherd R.K. Schwann cells genetically modified to express neurotrophins promote spiral ganglion neuron survival in vitro. Neuroscience 152 (2008) 821-828
28. Plontke S.K., Siedow N., Wegener R., Zenner H.P., and Salt A.N. Cochlear pharmacokinetics with local inner ear drug delivery using a three-dimensional finite-element computer model. Audiol. Neurootol. 12 (2007) 37-48
29. Rogowski M., Reiss G., and Lehnhardt E. Morphologic study of the guinea pig cochlea after cochlear implantation using the "soft surgery" technique. Ann. Otol. Rhinol. Laryngol. Suppl. 166 (1995) 434-436
30. Salt A.N. Simulation of methods for drug delivery to the cochlear fluids. Adv. Otorhinolaryngol. 59 (2002) 140-148
31. Salt A.N., and Plontke S.K. Local inner-ear drug delivery and pharmacokinetics. Drug Discov. Today 10 (2005) 1299-1306
32. Sasson R., and Amsterdam A. Pleiotropic anti-apoptotic activity of glucocorticoids in ovarian follicular cells. Biochem. Pharmacol. 66 (2003) 1393-1401
33. Silverstein, H., Choo, D., Rosenberg, S.I., Kuhn, J., Seidman, M., Stein, I. 1996. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J. 75, 468-471, 474, 476 passim.
34. Turner C.W., Reiss L.A., and Gantz B.J. Combined acoustic and electric hearing: preserving residual acoustic hearing. Hear. Res. 242 (2008) 164-171
35. Wu W.J., Sha S.H., and Schacht J. Recent advances in understanding aminoglycoside ototoxicity and its prevention. Audiol. Neurootol. 7 (2002) 171-174
36. Ye Q., Kiefer J., Tillein J., Klinke R., and Gstoettner W. Intracochlear application of steroids: an experimental study in guinea pigs. Cochlear Implants Int. 5 Suppl. 1 (2004) 17-18
37. Ye Q., Tillein J., Hartmann R., Gstoettner W., and Kiefer J. Application of a corticosteroid (Triamcinolon) protects inner ear function after surgical intervention. Ear Hear. 28 (2007) 361-369